StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)

Close on Nov 18, 2026Market cap $969.77MP/E –Yield –

Savara operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Savara's operating income for the twelve months ending Jun 30, 2026 was -$143.63M. For fiscal 2025 it was -$123.55M. The highest annual figure on record is -$5.92M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$123.55M–
FY2024Dec 31, 2024-$103.20M–
FY2023Dec 31, 2023-$60.01M–
FY2022Dec 31, 2022-$38.84M–
FY2021Dec 31, 2021-$41.48M–
FY2020Dec 31, 2020-$49.30M–
FY2019Dec 31, 2019-$79.03M–
FY2018Dec 31, 2018-$70.05M–
FY2017Dec 31, 2017-$29.96M–
FY2016Dec 31, 2016-$10.95M–
FY2015Dec 31, 2015-$5.92M–
FY2014Dec 31, 2014-$29.28M–
FY2013Dec 31, 2013-$21.54M–
FY2012Dec 31, 2012-$15.63M–
FY2011Dec 31, 2011-$13.40M–
FY2010Dec 31, 2010-$8.54M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.97M–
Q1 FY2026Mar 31, 2026-$38.99M–
Q4 FY2025Dec 31, 2025-$33.42M–
Q3 FY2025Sep 30, 2025-$30.26M–
Q2 FY2025Jun 30, 2025-$31.44M–
Q1 FY2025Mar 31, 2025-$28.44M–
Q4 FY2024Dec 31, 2024-$31.17M–
Q3 FY2024Sep 30, 2024-$26.36M–
Q2 FY2024Jun 30, 2024-$23.19M–
Q1 FY2024Mar 31, 2024-$22.48M–
Q4 FY2023Dec 31, 2023-$17.63M–
Q3 FY2023Sep 30, 2023-$18.04M–
Q2 FY2023Jun 30, 2023-$12.22M–
Q1 FY2023Mar 31, 2023-$12.11M–
Q4 FY2022Dec 31, 2022-$10.88M–
Q3 FY2022Sep 30, 2022-$10.54M–
Q2 FY2022Jun 30, 2022-$9.38M–
Q1 FY2022Mar 31, 2022-$8.05M–
Q4 FY2021Dec 31, 2021-$10.64M–
Q3 FY2021Sep 30, 2021-$9.97M–
Q2 FY2021Jun 30, 2021-$10.45M–
Q1 FY2021Mar 31, 2021-$10.41M–
Q4 FY2020Dec 31, 2020-$13.01M–
Q3 FY2020Sep 30, 2020-$10.79M–
Q2 FY2020Jun 30, 2020-$9.26M–
Q1 FY2020Mar 31, 2020-$16.24M–
Q4 FY2019Dec 31, 2019-$31.51M–
Q3 FY2019Sep 30, 2019-$12.44M–
Q2 FY2019Jun 30, 2019-$22.15M–
Q1 FY2019Mar 31, 2019-$12.92M–
Q4 FY2018Dec 31, 2018-$13.25M–
Q3 FY2018Sep 30, 2018-$12.78M–
Q2 FY2018Jun 30, 2018-$11.91M–
Q1 FY2018Mar 31, 2018-$32.11M–
Q4 FY2017Dec 31, 2017-$9.30M–
Q3 FY2017Sep 30, 2017-$6.54M–
Q2 FY2017Jun 30, 2017-$9.34M–
Q1 FY2017Mar 31, 2017-$4.77M–
Q4 FY2016Dec 31, 2016-$4.04M–
Q3 FY2016Sep 30, 2016-$3.23M–

More Savara figures

See a number that looks wrong?